Rakovina Therapeutics (TSXV:RKV) FCF Yield % : -24.88 (As of Jun. 19, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Rakovina Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Rakovina Therapeutics's Trailing 12-Month Free Cash Flow is C$-1.83 Mil, and Market Cap is C$7.36 Mil. Therefore, Rakovina Therapeutics's FCF Yield % for today is -24.88%.

The historical rank and industry rank for Rakovina Therapeutics's FCF Yield % or its related term are showing as below:

TSXV:RKV' s FCF Yield % Range Over the Past 10 Years
Min: -51.44 Med: 0 Max: 0
Current: -24.88

TSXV:RKV's FCF Yield % is ranked worse than
60.13% of 1550 companies
in the Biotechnology industry
Industry Median: -14.51 vs TSXV:RKV: -24.88

Rakovina Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

Rakovina Therapeutics FCF Yield % Historical Data

The historical data trend for Rakovina Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rakovina Therapeutics FCF Yield % Chart

Rakovina Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

FCF Yield %

-15.03

-15.25

-31.26

Rakovina Therapeutics Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial								-10.68	-33.95	-20.57	-25.31	-14.78

Competitive Comparison of Rakovina Therapeutics's FCF Yield %

For the Biotechnology subindustry, Rakovina Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rakovina Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rakovina Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Rakovina Therapeutics's FCF Yield % falls into.

Rakovina Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Rakovina Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-1.862	/	5.9572165
	=	-31.26%

Rakovina Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.259	*	4	/	7.00849
	=	-14.78%

Rakovina Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Rakovina Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Rakovina Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rakovina Therapeutics (TSXV:RKV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rakovina Therapeutics Inc (TSXV:RKV) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

RKVTF:USA

Address

8 Smithe Mews, Suite 2201, Vancouver, BC, CAN, V6B 0A5

Website

https://www.rakovinatherapeutics.com

Rakovina Therapeutics Inc is engaged in drug discovery research, preclinical and clinical development, and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Its oncology pipeline has the potential to deliver biomarker-driven treatments for patients across multiple tumor types. Some f its products in the pipeline include kt-2000 Next Generation PARP-inhibitors, kt-3000 Dual Action DDR-inhibitors, and kt-4000 DNA Damaging DDR-inhibitors.

Executives

Alfredo De Lucrezia

Director, Senior Officer

Rakovina Therapeutics (TSXV:RKV) Headlines

No Headlines